WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
Phase 4
Terminated
- Conditions
- Depressive DisorderMajor Depressive DisorderDepressionDepressive EpisodeDepression, Unipolar
- Interventions
- Other: GeneSight Psychotropic testDrug: FDA-approved antidepressant or antipsychotic treatment
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT03537547
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Localization of Peripheral Pulmonary Lesions: A Pilot Study
Phase 1
Withdrawn
- Conditions
- Peripheral Lung Lesions
- Interventions
- Procedure: Conventional bronchoscopyDevice: VIDA Pulmonary Workstation 2Procedure: Biopsy
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT03536026
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
Phase 1
Completed
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer
- Interventions
- Biological: PROSTVAC-VBiological: PROSTVAC-FBiological: Neoantigen DNA vaccineDevice: TriGrid Delivery SystemProcedure: Tumor biopsyProcedure: Peripheral bloodProcedure: Fecal samplesProcedure: Leukapheresis
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03532217
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Phase 2
Active, not recruiting
- Conditions
- GliomaGlioblastoma
- Interventions
- Radiation: Radiation therapyProcedure: Peripheral blood draw
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 51
- Registration Number
- NCT03532295
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Ocular Changes After Ivermectin - (DOLF IVM/Oncho)
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 231
- Registration Number
- NCT03517462
- Locations
- 🇬🇭
University of Health and Allied Sciences, Hohoe, Ghana
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Phase 1
Recruiting
- Conditions
- Rectal Cancer
- Interventions
- Radiation: Short-course radiation therapyDrug: CAPOX chemotherapyDrug: FOLFOX chemotherapy
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 49
- Registration Number
- NCT03516708
- Locations
- 🇺🇸
University of California Irvine - Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Henry Ford Cancer Institute, Detroit, Michigan, United States
Effect of Number of Remote Limb Ischemic Conditioning Cycles on Learning Enhancement
Phase 1
Completed
- Conditions
- Healthy, Young Adults
- Interventions
- Behavioral: RLIC - 5 cyclesBehavioral: RLIC - 4 CyclesBehavioral: RLIC - 3 CyclesBehavioral: Sham conditioningBehavioral: Balance trainingBehavioral: Arm trainingBehavioral: Sequence production training
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2019-08-26
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT03512041
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Remote Limb Ischemic Conditioning to Enhance Learning and Muscle Strength in Healthy Young Adults
Phase 1
Completed
- Conditions
- Healthy, Young Adults
- Interventions
- Behavioral: RLICBehavioral: Sham conditioningBehavioral: Muscle strength trainingBehavioral: Driving trainingBehavioral: Balance training
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT03512028
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
Phase 1
Terminated
- Conditions
- Gastroesophageal Junction AdenocarcinomaGastric CancerSolid TumorHepatocellular Carcinoma
- Interventions
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT03511222
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 1
Completed
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Procedure: BiopsyProcedure: Peripheral blood
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT03496662
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath